Study: IT Pros Lack Expertise to Handle Federal Mandates

Feb. 19, 2015
Three out of five healthcare IT professionals believe that government mandates are having a negative effect on their industry, according to study from Peak 10, a Charlotte, N.C.-based national IT infrastructure and cloud services provider.

Three out of five healthcare IT professionals believe that government mandates are having a negative effect on their industry, according to study from Peak 10, a Charlotte, N.C.-based national IT infrastructure and cloud services provider.

The majority (94 percent) of respondents also noted that complying with regulations influences IT strategy and decision-making.  With rare exception, respondents—C-level executives and information technology professionals at 149 U.S. healthcare organizations— claimed they lack the expertise necessary to navigate the maze of government regulations.

According to the study, cost cutting and cost containment are also cause for concern for healthcare organizations and exacerbated by the fact that many IT departments are already under-staffed and under-funded. Other key findings include:

Healthcare companies are cautiously but steadily moving into the cloud with software-as-service (SaaS) and non-mission critical workloads (administrative/corporate systems). Cloud adoption is mainly driven by regulatory mandates around electronic health records (EHRs).

  • Mobility, EHR, patient portals, and regulation are the critical technology topics that will make the greatest impact on healthcare IT environments.
  • Insurance organizations' budgets are under the most pressure: a 59 percent majority indicated that their IT budgets would either decline (25 percent) or remain static (38 percent) over the next two years. By contrast only one-third —34 percent—of insurance firms polled said IT budgets would increase over the next 24 months.
  • Presently, about 50 percent of IT healthcare companies surveyed indicated they use a third-party integrator or partner to assist them with their IT strategy.
  • Among the 50 percent of healthcare IT companies that use a third-party integrator/partner to assist with IT strategy, 70 percent cited depth of technical knowledge as the top reason. This was followed by 60 percent who indicated that third-party partners alleviate the time and resource constraints on internal IT staff.

"Healthcare organizations need a smooth transition to electronic health record systems," Christina Kyriazi, manager of market insights and analytics at Peak 10, said in a statement. "Technology is seen as the enabler to a better patient experience, giving patients more control over their personal information and healthcare history, therefore empowering them to trust their healthcare provider and to make more sound and well-informed decisions for themselves."

Sponsored Recommendations

Ask the Expert: Is Your Patients' Understanding Putting You at Risk?

Effective health literacy in healthcare is essential for ensuring informed consent, reducing medical malpractice risks, and enhancing patient-provider communication. Unfortunately...

Beyond the Silos: Transforming Coordinated Care Across Healthcare Systems

Coordinated healthcare is vital to delivering a high-quality patient experience, yet it has been difficult to systematize across all healthcare settings. Although it has largely...

The Healthcare Provider's Guide to Accelerating Clinician Onboarding

Improve clinician satisfaction and productivity to enhance patient care

ASK THE EXPERT: ServiceNow’s Erin Smithouser on what C-suite healthcare executives need to know about artificial intelligence

Generative artificial intelligence, also known as GenAI, learns from vast amounts of existing data and large language models to help healthcare organizations improve hospital ...

According to an Oct. 10 press release, a report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR). While some of these vaccines are already available but underused, others would need to be developed and brought to the market as soon as possible. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to antimicrobial medicines, making people sicker and increasing the risk of illness, death and the spread of infections that are difficult to treat. AMR is driven largely by the misuse and overuse of antimicrobials, yet, at the same time, many people around the world do not have access to essential antimicrobials. Each year, nearly 5 million deaths are associated with AMR globally. Vaccines are an essential part of the response to reduce AMR as they prevent infections, reduce the use and overuse of antimicrobials, and slow the emergence and spread of drug-resistant pathogens. The new report expands on a WHO study published in BMJ Global Health last year. It estimates that vaccines already in use against pneumococcus pneumonia, Haemophilus influenzae type B (Hib, a bacteria causing pneumonia and meningitis) and typhoid could avert up to 106 000 of the deaths associated with AMR each year. An additional 543 000 deaths associated with AMR could be averted annually when new vaccines for tuberculosis (TB) and Klebsiella pneumoniae, are developed and rolled out globally. While new TB vaccines are in clinical trials, one against Klebsiella pneumoniae is in early stage of development.
dreamstime_xxl_210174616_1